Jeannette L Salgado-Montilla1, Jorge L Rodríguez-Cabán2, Jonathan Sánchez-García3, Ricardo Sánchez-Ortiz4, Margarita Irizarry-Ramírez2. 1. University of Puerto Rico/MD Anderson Cancer Center Partnership for Excellence in Cancer Research, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico, USA. 2. School of Health Professions, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico, USA. 3. School of Public Health, Department of Biostatistics and Epidemiology, University of Puerto Rico, Medical Sciences Campus, San Juan, Rico, USA. 4. School of Medicine, Urology Section, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico, USA.
Abstract
BACKGROUND: Obesity is prevalent in PR and has been associated with prostate cancer (PCa) mortality and aggressiveness. Polymorphisms (SNPs) rs9930506 and rs9939609 in the FTO gene have been associated with both obesity and PCa. The aim of this work was to ascertain whether the presence of these SNPs is associated with PCa risk and severity in a cohort of Puerto Rican men. METHODS AND FINDINGS: The study population consisted of 513 Puerto Rican men age ranging from 40-79 years old who underwent radical prostatectomy (RP) as the first treatment for PCa and 128 healthy Puerto Rican men age ranging from 40-79 years old. Genomic DNA (gDNA) was extracted and SNPs were determined by Real-Time PCR. PCa severity was defined based on RP stage and Gleason Score. The relationship of FTO SNPs with demographic, clinical characteristics, PCa status and PCa severity were assessed. Logistic regression models with a 95% confidence interval (CI) determined SNPs interaction with PCa risk and severity odds ratio (ORs). RESULTS AND DISCUSSION: BMI, age and PSA were considered as confounders. Hardy-Weinberg equilibrium was present for both SNPs. The heterozygous forms (A/G; T/A) were the most prevalent genotypes and the frequency of alleles and genotypes for both SNPs agreed with those published in 1000 genomes. Results suggest an inverse association between the mutated rs9939609 and the risk of having PCa (OR: 0.53, 95% CI: 0.31-0.92) and a positive association with overweight (OR: 1.05, 95% CI: 0.68-1.62). Importantly, among the cases that were overweight, those with mutated rs9939609 had a greater chance of high severity PCa (OR: 1.39, 95% CI: 0.84-2.32) although these results were not statistical significant upon adjustment. Limitations of the study were the relatively small cohort and lack of access to the weight history of all our subjects. CONCLUSION: Results offer a research line to be followed with an expanded number of subjects that may provide a better statistical significance, to unravel the high mortality rate in this population.
BACKGROUND: Obesity is prevalent in PR and has been associated with prostate cancer (PCa) mortality and aggressiveness. Polymorphisms (SNPs) rs9930506 and rs9939609 in the FTO gene have been associated with both obesity and PCa. The aim of this work was to ascertain whether the presence of these SNPs is associated with PCa risk and severity in a cohort of Puerto Rican men. METHODS AND FINDINGS: The study population consisted of 513 Puerto Rican men age ranging from 40-79 years old who underwent radical prostatectomy (RP) as the first treatment for PCa and 128 healthy Puerto Rican men age ranging from 40-79 years old. Genomic DNA (gDNA) was extracted and SNPs were determined by Real-Time PCR. PCa severity was defined based on RP stage and Gleason Score. The relationship of FTO SNPs with demographic, clinical characteristics, PCa status and PCa severity were assessed. Logistic regression models with a 95% confidence interval (CI) determined SNPs interaction with PCa risk and severity odds ratio (ORs). RESULTS AND DISCUSSION: BMI, age and PSA were considered as confounders. Hardy-Weinberg equilibrium was present for both SNPs. The heterozygous forms (A/G; T/A) were the most prevalent genotypes and the frequency of alleles and genotypes for both SNPs agreed with those published in 1000 genomes. Results suggest an inverse association between the mutated rs9939609 and the risk of having PCa (OR: 0.53, 95% CI: 0.31-0.92) and a positive association with overweight (OR: 1.05, 95% CI: 0.68-1.62). Importantly, among the cases that were overweight, those with mutated rs9939609 had a greater chance of high severity PCa (OR: 1.39, 95% CI: 0.84-2.32) although these results were not statistical significant upon adjustment. Limitations of the study were the relatively small cohort and lack of access to the weight history of all our subjects. CONCLUSION: Results offer a research line to be followed with an expanded number of subjects that may provide a better statistical significance, to unravel the high mortality rate in this population.
Authors: Julie K Bassett; Gianluca Severi; Laura Baglietto; Robert J MacInnis; Hoa N Hoang; John L Hopper; Dallas R English; Graham G Giles Journal: Int J Cancer Date: 2012-02-28 Impact factor: 7.396
Authors: Christel Häggström; Tanja Stocks; David Ulmert; Tone Bjørge; Hanno Ulmer; Göran Hallmans; Jonas Manjer; Anders Engeland; Gabriele Nagel; Martin Almqvist; Randi Selmer; Hans Concin; Steinar Tretli; Håkan Jonsson; Pär Stattin Journal: Cancer Date: 2012-10-22 Impact factor: 6.860
Authors: S Sebert; T Salonurmi; S Keinänen-Kiukaanniemi; M Savolainen; K-H Herzig; M E Symonds; M-R Järvelin Journal: Acta Physiol (Oxf) Date: 2013-11-27 Impact factor: 6.311
Authors: Adam Auton; Lisa D Brooks; Richard M Durbin; Erik P Garrison; Hyun Min Kang; Jan O Korbel; Jonathan L Marchini; Shane McCarthy; Gil A McVean; Gonçalo R Abecasis Journal: Nature Date: 2015-10-01 Impact factor: 49.962
Authors: Angelo Scuteri; Serena Sanna; Wei-Min Chen; Manuela Uda; Giuseppe Albai; James Strait; Samer Najjar; Ramaiah Nagaraja; Marco Orrú; Gianluca Usala; Mariano Dei; Sandra Lai; Andrea Maschio; Fabio Busonero; Antonella Mulas; Georg B Ehret; Ashley A Fink; Alan B Weder; Richard S Cooper; Pilar Galan; Aravinda Chakravarti; David Schlessinger; Antonio Cao; Edward Lakatta; Gonçalo R Abecasis Journal: PLoS Genet Date: 2007-07 Impact factor: 5.917
Authors: N E Allen; T J Key; P N Appleby; R C Travis; A W Roddam; A Tjønneland; N F Johnsen; K Overvad; J Linseisen; S Rohrmann; H Boeing; T Pischon; H B Bueno-de-Mesquita; L Kiemeney; G Tagliabue; D Palli; P Vineis; R Tumino; A Trichopoulou; C Kassapa; D Trichopoulos; E Ardanaz; N Larrañaga; M-J Tormo; C A González; J R Quirós; M-J Sánchez; S Bingham; K-T Khaw; J Manjer; G Berglund; P Stattin; G Hallmans; N Slimani; P Ferrari; S Rinaldi; E Riboli Journal: Br J Cancer Date: 2008-04-01 Impact factor: 7.640
Authors: Andrés Moreno-Estrada; Simon Gravel; Fouad Zakharia; Jacob L McCauley; Jake K Byrnes; Christopher R Gignoux; Patricia A Ortiz-Tello; Ricardo J Martínez; Dale J Hedges; Richard W Morris; Celeste Eng; Karla Sandoval; Suehelay Acevedo-Acevedo; Paul J Norman; Zulay Layrisse; Peter Parham; Juan Carlos Martínez-Cruzado; Esteban González Burchard; Michael L Cuccaro; Eden R Martin; Carlos D Bustamante Journal: PLoS Genet Date: 2013-11-14 Impact factor: 5.917
Authors: Ethan M Lange; Anna M Johnson; Yunfei Wang; Kimberly A Zuhlke; Yurong Lu; Jessica V Ribado; Gregory R Keele; Jin Li; Qing Duan; Ge Li; Zhengrong Gao; Yun Li; Jianfeng Xu; William B Isaacs; Siqun Zheng; Kathleen A Cooney Journal: PLoS One Date: 2014-04-16 Impact factor: 3.240
Authors: José Manuel Sánchez-Maldonado; Ricardo Collado; Antonio José Cabrera-Serrano; Rob Ter Horst; Fernando Gálvez-Montosa; Inmaculada Robles-Fernández; Verónica Arenas-Rodríguez; Blanca Cano-Gutiérrez; Olivier Bakker; María Inmaculada Bravo-Fernández; Francisco José García-Verdejo; José Antonio López López; Jesús Olivares-Ruiz; Miguel Ángel López-Nevot; Laura Fernández-Puerta; José Manuel Cózar-Olmo; Yang Li; Mihai G Netea; Manuel Jurado; Jose Antonio Lorente; Pedro Sánchez-Rovira; María Jesús Álvarez-Cubero; Juan Sainz Journal: Cancers (Basel) Date: 2022-05-12 Impact factor: 6.575
Authors: Briseida E Feliciano-Astacio; Katrina Celis; Jairo Ramos; Farid Rajabli; Larry Deon Adams; Alejandra Rodriguez; Vanessa Rodriguez; Parker L Bussies; Carolina Sierra; Patricia Manrique; Pedro R Mena; Antonella Grana; Michael Prough; Kara L Hamilton-Nelson; Nereida Feliciano; Angel Chinea; Heriberto Acosta; Jacob L McCauley; Jeffery M Vance; Gary W Beecham; Margaret A Pericak-Vance; Michael L Cuccaro Journal: Front Genet Date: 2019-06-19 Impact factor: 4.599